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Hematoporphyrin derivative, a photosensitive material
used to identify and treat neoplastic tissue in humans,
has been found to localize in atheromatous plaques in
animals and has recently been found in postmortem hu-
man atherosclerotic plaques. It is not known whether
human plaques take up hematoporphyrin derivative in
vivo. In five patients undergoing surgical vascular pro-
cedures, specimenscontaining atheromatous plaques were
removed and immediately incubated in autologous ox-
ygenated blood at 37°Cwith hematoporphyrin derivative
at a clinically relevant concentration for 2 hours. On
exposure to ultraviolet light, porphyrin fluorescence was
noted throughout each plaque, whereas adjacent plaque-
free tissue showed no fluorescence.
To compare in vitro with in vivo hematoporphyrin
Intravenously injected hematoporphyrin derivative has been
shown to have a selective affinity for experimental diet-
induced atheromatous plaques compared with the plaque-
free arterial wall (1), as well as for human postmortem
atheromatous plaques (2). The potential therefore exists for
selective photochemical treatment of atheromatous plaques,
because photodynamic therapy of hematoporphyrin deriv-
ative-retaining malignant neoplasms has proved useful clin-
ically (3,4). However, such potential cannot be evaluated
satisfactorily until more evidence is provided showing that
human atheromatous plaques concentrate hematoporphyrin
derivative in vivo. In clinical tumor trials, no significant
adverse effects with the use of hematoporphyrin derivative
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derivative uptake by plaques, the fluorescence of three
types of arterial lesions (induced by a high cholesterol
diet, catheters or balloon injury) was studied in 16 New
Zealand White rabbits. Each lesionfluoresced selectively
with the same intensity whether hematoporphyrin de-
rivative exposure was performed in vitro or in vivo.
Fluorescence microscopy did not show a difference in
the pattern of hematoporphyrin derivative fluorescence
between in vitro and in vivo specimens.
The results suggest that human atheromatous plaques
should take up hematoporphyrin derivative in vivo and
are, therefore, potentially suitable for photochemical
treatment as a new therapeutic approach to atheroscle-
rosis.
(J Am Coli CardioI1986;8:1387-92)
have been observed other than increased skin photosensi-
tivity for 4 to 6 weeks after injection of the drug. Parenteral
injection of hematoporphyrin derivative at this time to as-
certain whether selective localization in plaque occurs in
humans does not seem justified because of this limiting side
effect and because patients would not derive any therapeutic
benefit. However, in vitro studies of human plaques can be
meaningful if the relevance of this kind of study is dem-
onstrated experimentally by a comparison of in vitro with
in vivo models.
We therefore studied the in vitro uptake of hematopor-
phyrin derivative by human atheromatous arterial plaques
removed from patients at the time of a vascular procedure,
in a manner that simulates in vivo conditions; that is, plaques
were incubated in autologous oxygenated blood at 37°C with
hematoporphyrin derivative at a clinically relevant concen-
tration for 2 hours. The relevance of these in vitro studies
was examined by comparing the in vitro uptake of hema-
toporphyrin derivative by various types of experimental ath-
eromatous lesions with their hematoporphyrin derivative up-
take in vivo. Furthermore, studies with a variety of
experimental models may provide greater insight into the
potential uptake of hematoporphyrin derivative by different
types of human atheromatous lesions.
0735-1097/86/$3.50
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Methods
Human Studies
From the carotid arteries of four patients undergoing end-
arterectomy, and from the poplite al artery of a patient
unde rgoing a leg amputation, portions of the surgical spec-
imens containing atheromatous and plaque-free arterial wall
were immediately incubated in heparinized autologous blood
at 37°C for I hour in chambers containing hematoporphyrin
der ivative (20 jLg/ml). The chambers were gently mixed and
were gassed with a 95% oxygen :5% carbon dioxide mixture.
Immediately after incubation , each sample was rinsed with
0.15M sodium chloride and examined grossly with a Wood's
lamp. Informed consent was obtained for the surgical pro-
cedures, including permission for pathologic studies of ma-
terial removed from the body .
Rabbit Studi es in Vivo
Twenty-four New Zealand White male rabbits, weighing
about 4 kg each , were divided into three groups:
Group I: Diet-induced plaques. Six rabbits were fed
a high cholesterol diet for a period of 6 months as previou sly
described (I ). One to 2 days before death was induced ,
hemat oporphyrin derivative (5.0 mg/kg body weight) (Pho-
tofrin II) was injected intravenously . After rinsing the aortic
luminal surface with phosphate-buffered saline solution, lo-
calization of porph yrin fluorescence was performed with a
Wood ' s lamp .
Group II: Catheter injury. In 10 rabbit s, aort ic lesions
were induced mechanically by the presence of a chronically
indwelling polyethylene catheter as described by Moore (5).
The rabbits were anesthetized with diazepam and ketamine,
and a cutdown over a peripheral artery was performed with
lidocaine anesthesia. A polyethylene 90 tube was advanced
under fluoroscopy through the femoral artery in two rabbits
and through the carotid artery in four rabbits into the aorta
to the level of the diaphragm at the site of insertion. The
catheter was kept in place with a 2-0 silk ligature around
the carotid artery . One to 2 weeks after catheter insertion,
hematoporphyrin derivative was injected intravenously . The
rabbit s were killed with intravenous pentobarbital, either I
hour or I day after hematoporphyrin derivative injection ,
and the aorta was dissected free of adjacent tissues . Fluo-
rescence micro scopy was then performed on frozen sections
of both lesion-free aortic segments and segments containing
catheter-induced lesions.
Group III: Balloon injury. Balloon endothelial denu-
dation was performed in a manner similar to the techniqu e
described by others (6- 9). A cutdown was performed over
the femoral artery, as described earlier, in each of seven
rabbits. Under fluoroscopy , a 3F Shiley embolectomy cath-
eter was advanced to the level of the midthoracic aorta and,
after balloon inflation with contrast medium to a constant
pressure of 300 mm Hg, was withdrawn twice to the iliac
bifurcation for endothelial denudation in each rabbit. He-
matoporphyrin derivative (5 rug/kg) was given intravenously
immediately after denud ation . Two rabbit s were sacrificed
at I hour . and four rabbit s were sacrificed at 48 hours after
hematoporphyrin derivative admini stration , and the aorta
was studied in the same manner as for Group I. Two ad-
ditional rabbits were given 4 mg of 0.5 % (wt/vol) Evans
blue (Harvey Laboratories) intravenously along with he-
matoporphyrin derivative at the time of balloon injury and
were killed I hour later.
Rabbit Studies in Vitro
The aortas of 12 rabbits were studied in vitro in the same
fashion as the human specimens. Two aortas were obtained
from normal control rabbits . In addition, catheter-induced
lesions were produced, as described earlier, in four rabbit s
2 weeks before sacrifice , and balloon de-endothelialization
was performed in another four rabbits I hour before sacrifice
for the in vitro study . Two rabbits that had had a high
cholesterol diet for 5 months were used to provide a diet-
induced atheromatous aorta for in vitro studies. Under pen-
tobarbital anesthesia, the abdominal aorta of each rabbit was
exposed by way of a longitudin al ventral incision , and 80
cc of blood was remo ved with an 18 gauge needle . The
rabbits were killed with an overdose of intravenous pen-
tobarbital, and multiple I em normal and lesion-bearing
aortic segments were incubated in 40 cc of heparinized
autologous blood for I hour as described for the human
specimens.
Microscopic studies. Fluore scence microscopy was per-
formed on frozen section s of normal and lesion-bearing
aortic segments from each rabbit model. Automatic expo-
sure with a 35 mm Nikon single lens reflex camera facilitated
fluorescent and white light photographic documentation of
the findings as described previously ( I). Additional sect ions
of normal and lesion-bearing aortic segments from each
rabbit model were fixed in 10% neutral buffered formal in,
embedded in paraffin and treated with hematoxylin-eosin
stain for light microscopic examination.
Results
Human Studies
In each human specimen , atheromatous plaque showed
a fluorescence intensity intermed iate between that of the
balloon-injured segments and the experimental plaques in
rabbits. Fluorescen ce was observed throughout the thickne ss
of the plaque , and its intensity appeared to follow a con-
centration gradient from the luminal surface to the deepest
layers of each plaque. Normal tissue adjacent to or below
the plaque did not show any fluorescence. Calcium spicules
within the plaque did not fluoresce and appeared white
(Fig. I).
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Figure 1. Fresh human arterial specimen after incubation with
hematoporphyrin derivative in vitro for I hour. On exposure to
ultraviolet light, the atheromatous plaquefluoresces red incontrast
to the plaque-free arterial wall.
Rabbit Studies
In vivo. The aortas of hypercholesterolemic rabbits in-
jected with hematoporphyrin derivative appeared the same
under normal and ultraviolet light, as described previously
(I ) . Each rabbit aorta subjected to catheter-induced trauma
showed a plaque that was continuous with the aortic intima
and enclosed the distal end of the polyethylene tubing. On
exposure to ultraviolet light, each plaque demonstrated an
intense red fluorescence (Fig . 2) that appeared to be dis-
tributed throughout the thickness of each plaque , whereas
the underlying aortic wall was free of fluorescence .
The gross pattern and intensity of porphyrin fluorescence
was similar for rabbits killed I and 48 hours after balloon
injury and injection of hematoporphyrin derivative. A ho-
mogeneous distribution of mild fluorescence was noted over
the entire de-endothelialized luminal surface, whereas the
proximal noninjured aorta showed no fluorescence. The dis-
tribution of the porphyrin fluorescence correlated closely
with that of the Evans blue . The fluorescence intensity of
the mechanically induced and diet-induced plaques was greater
than that of the aortas subjected to balloon injury .
In vitro. Before incubation with hematoporphyrin de-
rivative, no aortic segment demonstrated nonspecific fluo-
rescence when examined with the Wood's lamp. No fluo-
rescence was noted in normal rabbit aortic segments incubated
with hematoporphyrin derivative in autologous blood, whereas
balloon-injured segments demonstrated mild fluorescence ,
and diet- and catheter-induced plaques showed intense flu-
orescence. Comparing the plaques of in vitro with in vivo
specimens under ultraviolet light , no difference in uptake
of hematoporphyrin derivative fluorescence could be seen
(Fig . 2) .
Microscopic Studies
Light microscopy. Light microscopic examination of
the various types of aortic lesions demonstrated pathologic
Figure 2. Catheter-induced rabbit aortic plaques incubated with
hematoporphyrin derivativefor I hour in vivo (right) and in vitro
(left). Atherosclerotic plaquesof bothaortasshowthe same intense
fluorescence when viewed under ultraviolet light.
changes similar to that described by others (5 ,9) and ranged
from the predominantly fatty streak-foam cell intimal thick-
ening of the diet-induced plaque to the thrombo-fibro-fatty
lesion of the catheter-injured aorta.
Fluorescence microscopy. The microscopic fluores-
cence pattern in the aortas of balloon-injured rabbits killed
I hour after hematoporphyrin derivative injection was sim-
ilar to that of the balloon-injured aortic segments incubated
with hematoporphyrin derivative in vitro. A diffuse, nearly
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Figure 3. Microscopic patternof red
fluorescence within intima of diet-in-
ducedatheromatous rabbit aorta I hour
(A) and 2 days (B) after hematopor-
phyrin derivative injection.
continuous linear distribution of fluorescence in the sub-
endothelium adjacent to the luminal surface and between
elastic layers was evident in each case (Fig. 3).
Two days after hematoporphyrin derivative injection in
the in vivo studies, the microscopic pattern of fluorescence
was similar within all aortas, including catheter-induced and
hypercholesterolemia-induced plaques and balloon-injured
segments. This pattern differed markedly from that noted
within injured aortas 1 hour after hematoporphyrin deriv-
ative injection and consisted of small clusters of granular
fluorescence within the intima. The intensity of the granular
fluorescence appeared greater than that of the homogeneous
fluorescence noted I hour after hematoporphyrin derivative
injection. The media of these tissues and all layers of non-
injured aortas demonstrated no fluorescence.
Discussion
Human studies. Although the in vivo uptake of he-
matoporphyrin derivative by diet-induced arterial lesions in
rabbits and in a patas monkey has been previously reported
(1), it is unknown whether human atheromatous plaques
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also selectively concentrate hematoporphyrin derivative in
vivo, because the histologic findings of human atheromatous
plaque are variable and often differ markedly from those of
commonly used experimental models (5). The uptake of
porphyrins by postmortem human plaques was described by
Kessel and Sykes (2). However, the design of their study
may not permit extrapolation to the in vivo setting for several
reasons. First, cadaver specimens might have undergone
degenerative changes, thereby altering their affinity to he-
matoporphyrin derivative, which is known to be quite high
in injured and necrotic tissue (10). Second, incubation of
the specimens in Eagle's minimal essential medium does
not take into consideration the affinity of porphyrins for
plasma proteins. The latter may play an important role in
vivo in porphyrin bioavailability.
Rabbit studies. The aortas of all three models of aortic
injury in the rabbit demonstrated the same intensity whether
the specimens were exposed to hematoporphyrin derivative
in vitro or in vivo, although the intensity differed among
the various models. Fluorescence microscopy of both in vivo
and in vitro incubated arteries revealed a similar pattern
after 1 hour.
Mechanism of uptake. Because the exact mechanism
and specific site of hematoporphyrin derivative uptake by
tumors remains to be elucidated, it was beyond the scope
of this study to define the precise mechanism and site of
hematoporphyrin derivative uptake by atherosclerotic plaques.
There are several theories that might explain the uptake of
hematoporphyrin derivative by plaques. First, it has been
suggested that porphyrins have an affinity for rapidly pro-
liferating tissue, which would include malignant and ath-
erosclerotic tissues (10). Second, it has been reported that
non-neoplastic tissues, such as liver, kidney and spleen,
which are characterized by capillaries with either a fenes-
trated or a discontinuous endothelium, have a higher affinity
to hematoporphyrin derivative than do other normal tissues
(11-13). This indicates that increased endothelial permea-
bility, present in atherosclerosis, might account for hema-
toporphyrin derivative uptake. Third, an affinity of hema-
toporphyrin and other porphyrins for fibrinogen and platelets
has been described (14), and the latter two may play an
important role in atherogenesis. Finally, recent studies (15)
suggest that mononuclear cell adhesion and migration play
a central role in plaque progression, and mononuclear cell
phagocytosis of porphyrins bound to lipoproteins may oc-
cur.
The findings of this study suggest that accumulation of
hematoporphyrin derivative by human atheromatous plaques
is likely to occur for three reasons. First, strong retention
of hematoporphyrin derivative by experimental plaques, in-
cluding the catheter-induced plaque which may bear a closer
histologic resemblance to human plaques than to diet-in-
duced lesions (5), occurs irrespective of plaque origin. Sec-
ond, injury to the arterial wall is commonly accepted as a
substrate for lesion progression (5,8,9,16), and the affinity
of hematoporphyrin derivative for the aortic intima was
enhanced experimentally by all forms of injury. Finally,
because the in vitro studies in rabbits produced results that
were both macroscopically and microscopically similar to
those of the in vivo studies, it is likely that the in vivo
uptake by human plaques of hematoporphyrin derivative
will be similar to their uptake of hematoporphyrin derivative
in vitro.
Potential use. Selective uptake of hematoporphyrin de-
rivative by atheromatous plaques in humans may be useful
clinically. In our previous experience with angioscopy (17),
the boundary between plaque and the normal arterial wall
could not be easily defined. However, on exposure to ul-
traviolet light, hematoporphyrin derivative fluorescence of
atherosclerotic plaques could facilitate lesion identification.
For therapeutic purposes, hematoporphyrin derivative could
be used as a selective chromophore in laser angioplasty to
enhance absorption of laser energy (for example, argon ion
laser), thereby reducing potential adverse effects such as
perforation (18).
Because the patchy distribution of granular fluorescence
noted in the present study is similar to that found in biopsy
specimens of tumors that have subsequently responded suc-
cessfully to photodynamic therapy with hematoporphyrin
derivative (T.J. Dougherty, personal communication), pho-
tochemical treatment of atherosclerotic disease might be
possible. Because no significant adverse effect other than
increased skin photosensitivity has been described for par-
enterally injected hematoporphyrin derivative, this drug may
be beneficial for this purpose. However, in addition to the
potential problems discussed previously (1), the exact mech-
anism of tumor destruction is unclear, so that the potential
for successful treatment of porphyrin-laden plaques is dif-
ficult to estimate. Additional studies of porphyrin-mediated
photodynamic tissue reactions in general are required to
address these practical issues.
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